Global Prostate Specific Antigen Market Growth 2025-2031
The global Prostate Specific Antigen market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
United States market for Prostate Specific Antigen is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Prostate Specific Antigen is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Prostate Specific Antigen is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Prostate Specific Antigen players cover Advaxis, Inc., Aeterna Zentaris Inc., Bavarian Nordic A/S, Curevac AG, GenSpera, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the ?Prostate Specific Antigen Industry Forecast? looks at past sales and reviews total world Prostate Specific Antigen sales in 2024, providing a comprehensive analysis by region and market sector of projected Prostate Specific Antigen sales for 2025 through 2031. With Prostate Specific Antigen sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prostate Specific Antigen industry.
This Insight Report provides a comprehensive analysis of the global Prostate Specific Antigen landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Prostate Specific Antigen portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Prostate Specific Antigen market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prostate Specific Antigen and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prostate Specific Antigen.
This report presents a comprehensive overview, market shares, and growth opportunities of Prostate Specific Antigen market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Prostate Specific Antigen market?
What factors are driving Prostate Specific Antigen market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Prostate Specific Antigen market opportunities vary by end market size?
How does Prostate Specific Antigen break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
United States market for Prostate Specific Antigen is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Prostate Specific Antigen is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Prostate Specific Antigen is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Prostate Specific Antigen players cover Advaxis, Inc., Aeterna Zentaris Inc., Bavarian Nordic A/S, Curevac AG, GenSpera, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the ?Prostate Specific Antigen Industry Forecast? looks at past sales and reviews total world Prostate Specific Antigen sales in 2024, providing a comprehensive analysis by region and market sector of projected Prostate Specific Antigen sales for 2025 through 2031. With Prostate Specific Antigen sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prostate Specific Antigen industry.
This Insight Report provides a comprehensive analysis of the global Prostate Specific Antigen landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Prostate Specific Antigen portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Prostate Specific Antigen market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prostate Specific Antigen and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prostate Specific Antigen.
This report presents a comprehensive overview, market shares, and growth opportunities of Prostate Specific Antigen market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- G-115
- INO-5150
- ADXS-PSA
- AEZS-120
- Others
- Prostate Cancer
- Metastatic Hormone Refractory Prostate Cancer
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Advaxis, Inc.
- Aeterna Zentaris Inc.
- Bavarian Nordic A/S
- Curevac AG
- GenSpera, Inc.
- Inovio Pharmaceuticals, Inc.
- OncBioMune Pharmaceuticals Inc.
What is the 10-year outlook for the global Prostate Specific Antigen market?
What factors are driving Prostate Specific Antigen market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Prostate Specific Antigen market opportunities vary by end market size?
How does Prostate Specific Antigen break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Prostate Specific Antigen Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Prostate Specific Antigen by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Prostate Specific Antigen by Country/Region, 2020, 2024 & 2031
2.2 Prostate Specific Antigen Segment by Type
2.2.1 G-115
2.2.2 INO-5150
2.2.3 ADXS-PSA
2.2.4 AEZS-120
2.2.5 Others
2.3 Prostate Specific Antigen Sales by Type
2.3.1 Global Prostate Specific Antigen Sales Market Share by Type (2020-2025)
2.3.2 Global Prostate Specific Antigen Revenue and Market Share by Type (2020-2025)
2.3.3 Global Prostate Specific Antigen Sale Price by Type (2020-2025)
2.4 Prostate Specific Antigen Segment by Application
2.4.1 Prostate Cancer
2.4.2 Metastatic Hormone Refractory Prostate Cancer
2.4.3 Others
2.5 Prostate Specific Antigen Sales by Application
2.5.1 Global Prostate Specific Antigen Sale Market Share by Application (2020-2025)
2.5.2 Global Prostate Specific Antigen Revenue and Market Share by Application (2020-2025)
2.5.3 Global Prostate Specific Antigen Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Prostate Specific Antigen Breakdown Data by Company
3.1.1 Global Prostate Specific Antigen Annual Sales by Company (2020-2025)
3.1.2 Global Prostate Specific Antigen Sales Market Share by Company (2020-2025)
3.2 Global Prostate Specific Antigen Annual Revenue by Company (2020-2025)
3.2.1 Global Prostate Specific Antigen Revenue by Company (2020-2025)
3.2.2 Global Prostate Specific Antigen Revenue Market Share by Company (2020-2025)
3.3 Global Prostate Specific Antigen Sale Price by Company
3.4 Key Manufacturers Prostate Specific Antigen Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Prostate Specific Antigen Product Location Distribution
3.4.2 Players Prostate Specific Antigen Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PROSTATE SPECIFIC ANTIGEN BY GEOGRAPHIC REGION
4.1 World Historic Prostate Specific Antigen Market Size by Geographic Region (2020-2025)
4.1.1 Global Prostate Specific Antigen Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Prostate Specific Antigen Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Prostate Specific Antigen Market Size by Country/Region (2020-2025)
4.2.1 Global Prostate Specific Antigen Annual Sales by Country/Region (2020-2025)
4.2.2 Global Prostate Specific Antigen Annual Revenue by Country/Region (2020-2025)
4.3 Americas Prostate Specific Antigen Sales Growth
4.4 APAC Prostate Specific Antigen Sales Growth
4.5 Europe Prostate Specific Antigen Sales Growth
4.6 Middle East & Africa Prostate Specific Antigen Sales Growth
5 AMERICAS
5.1 Americas Prostate Specific Antigen Sales by Country
5.1.1 Americas Prostate Specific Antigen Sales by Country (2020-2025)
5.1.2 Americas Prostate Specific Antigen Revenue by Country (2020-2025)
5.2 Americas Prostate Specific Antigen Sales by Type (2020-2025)
5.3 Americas Prostate Specific Antigen Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prostate Specific Antigen Sales by Region
6.1.1 APAC Prostate Specific Antigen Sales by Region (2020-2025)
6.1.2 APAC Prostate Specific Antigen Revenue by Region (2020-2025)
6.2 APAC Prostate Specific Antigen Sales by Type (2020-2025)
6.3 APAC Prostate Specific Antigen Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Prostate Specific Antigen by Country
7.1.1 Europe Prostate Specific Antigen Sales by Country (2020-2025)
7.1.2 Europe Prostate Specific Antigen Revenue by Country (2020-2025)
7.2 Europe Prostate Specific Antigen Sales by Type (2020-2025)
7.3 Europe Prostate Specific Antigen Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Prostate Specific Antigen by Country
8.1.1 Middle East & Africa Prostate Specific Antigen Sales by Country (2020-2025)
8.1.2 Middle East & Africa Prostate Specific Antigen Revenue by Country (2020-2025)
8.2 Middle East & Africa Prostate Specific Antigen Sales by Type (2020-2025)
8.3 Middle East & Africa Prostate Specific Antigen Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Prostate Specific Antigen
10.3 Manufacturing Process Analysis of Prostate Specific Antigen
10.4 Industry Chain Structure of Prostate Specific Antigen
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Prostate Specific Antigen Distributors
11.3 Prostate Specific Antigen Customer
12 WORLD FORECAST REVIEW FOR PROSTATE SPECIFIC ANTIGEN BY GEOGRAPHIC REGION
12.1 Global Prostate Specific Antigen Market Size Forecast by Region
12.1.1 Global Prostate Specific Antigen Forecast by Region (2026-2031)
12.1.2 Global Prostate Specific Antigen Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Prostate Specific Antigen Forecast by Type (2026-2031)
12.7 Global Prostate Specific Antigen Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Advaxis, Inc.
13.1.1 Advaxis, Inc. Company Information
13.1.2 Advaxis, Inc. Prostate Specific Antigen Product Portfolios and Specifications
13.1.3 Advaxis, Inc. Prostate Specific Antigen Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Advaxis, Inc. Main Business Overview
13.1.5 Advaxis, Inc. Latest Developments
13.2 Aeterna Zentaris Inc.
13.2.1 Aeterna Zentaris Inc. Company Information
13.2.2 Aeterna Zentaris Inc. Prostate Specific Antigen Product Portfolios and Specifications
13.2.3 Aeterna Zentaris Inc. Prostate Specific Antigen Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Aeterna Zentaris Inc. Main Business Overview
13.2.5 Aeterna Zentaris Inc. Latest Developments
13.3 Bavarian Nordic A/S
13.3.1 Bavarian Nordic A/S Company Information
13.3.2 Bavarian Nordic A/S Prostate Specific Antigen Product Portfolios and Specifications
13.3.3 Bavarian Nordic A/S Prostate Specific Antigen Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bavarian Nordic A/S Main Business Overview
13.3.5 Bavarian Nordic A/S Latest Developments
13.4 Curevac AG
13.4.1 Curevac AG Company Information
13.4.2 Curevac AG Prostate Specific Antigen Product Portfolios and Specifications
13.4.3 Curevac AG Prostate Specific Antigen Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Curevac AG Main Business Overview
13.4.5 Curevac AG Latest Developments
13.5 GenSpera, Inc.
13.5.1 GenSpera, Inc. Company Information
13.5.2 GenSpera, Inc. Prostate Specific Antigen Product Portfolios and Specifications
13.5.3 GenSpera, Inc. Prostate Specific Antigen Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 GenSpera, Inc. Main Business Overview
13.5.5 GenSpera, Inc. Latest Developments
13.6 Inovio Pharmaceuticals, Inc.
13.6.1 Inovio Pharmaceuticals, Inc. Company Information
13.6.2 Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Product Portfolios and Specifications
13.6.3 Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Inovio Pharmaceuticals, Inc. Main Business Overview
13.6.5 Inovio Pharmaceuticals, Inc. Latest Developments
13.7 OncBioMune Pharmaceuticals Inc.
13.7.1 OncBioMune Pharmaceuticals Inc. Company Information
13.7.2 OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Product Portfolios and Specifications
13.7.3 OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 OncBioMune Pharmaceuticals Inc. Main Business Overview
13.7.5 OncBioMune Pharmaceuticals Inc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Prostate Specific Antigen Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Prostate Specific Antigen by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Prostate Specific Antigen by Country/Region, 2020, 2024 & 2031
2.2 Prostate Specific Antigen Segment by Type
2.2.1 G-115
2.2.2 INO-5150
2.2.3 ADXS-PSA
2.2.4 AEZS-120
2.2.5 Others
2.3 Prostate Specific Antigen Sales by Type
2.3.1 Global Prostate Specific Antigen Sales Market Share by Type (2020-2025)
2.3.2 Global Prostate Specific Antigen Revenue and Market Share by Type (2020-2025)
2.3.3 Global Prostate Specific Antigen Sale Price by Type (2020-2025)
2.4 Prostate Specific Antigen Segment by Application
2.4.1 Prostate Cancer
2.4.2 Metastatic Hormone Refractory Prostate Cancer
2.4.3 Others
2.5 Prostate Specific Antigen Sales by Application
2.5.1 Global Prostate Specific Antigen Sale Market Share by Application (2020-2025)
2.5.2 Global Prostate Specific Antigen Revenue and Market Share by Application (2020-2025)
2.5.3 Global Prostate Specific Antigen Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Prostate Specific Antigen Breakdown Data by Company
3.1.1 Global Prostate Specific Antigen Annual Sales by Company (2020-2025)
3.1.2 Global Prostate Specific Antigen Sales Market Share by Company (2020-2025)
3.2 Global Prostate Specific Antigen Annual Revenue by Company (2020-2025)
3.2.1 Global Prostate Specific Antigen Revenue by Company (2020-2025)
3.2.2 Global Prostate Specific Antigen Revenue Market Share by Company (2020-2025)
3.3 Global Prostate Specific Antigen Sale Price by Company
3.4 Key Manufacturers Prostate Specific Antigen Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Prostate Specific Antigen Product Location Distribution
3.4.2 Players Prostate Specific Antigen Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PROSTATE SPECIFIC ANTIGEN BY GEOGRAPHIC REGION
4.1 World Historic Prostate Specific Antigen Market Size by Geographic Region (2020-2025)
4.1.1 Global Prostate Specific Antigen Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Prostate Specific Antigen Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Prostate Specific Antigen Market Size by Country/Region (2020-2025)
4.2.1 Global Prostate Specific Antigen Annual Sales by Country/Region (2020-2025)
4.2.2 Global Prostate Specific Antigen Annual Revenue by Country/Region (2020-2025)
4.3 Americas Prostate Specific Antigen Sales Growth
4.4 APAC Prostate Specific Antigen Sales Growth
4.5 Europe Prostate Specific Antigen Sales Growth
4.6 Middle East & Africa Prostate Specific Antigen Sales Growth
5 AMERICAS
5.1 Americas Prostate Specific Antigen Sales by Country
5.1.1 Americas Prostate Specific Antigen Sales by Country (2020-2025)
5.1.2 Americas Prostate Specific Antigen Revenue by Country (2020-2025)
5.2 Americas Prostate Specific Antigen Sales by Type (2020-2025)
5.3 Americas Prostate Specific Antigen Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prostate Specific Antigen Sales by Region
6.1.1 APAC Prostate Specific Antigen Sales by Region (2020-2025)
6.1.2 APAC Prostate Specific Antigen Revenue by Region (2020-2025)
6.2 APAC Prostate Specific Antigen Sales by Type (2020-2025)
6.3 APAC Prostate Specific Antigen Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Prostate Specific Antigen by Country
7.1.1 Europe Prostate Specific Antigen Sales by Country (2020-2025)
7.1.2 Europe Prostate Specific Antigen Revenue by Country (2020-2025)
7.2 Europe Prostate Specific Antigen Sales by Type (2020-2025)
7.3 Europe Prostate Specific Antigen Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Prostate Specific Antigen by Country
8.1.1 Middle East & Africa Prostate Specific Antigen Sales by Country (2020-2025)
8.1.2 Middle East & Africa Prostate Specific Antigen Revenue by Country (2020-2025)
8.2 Middle East & Africa Prostate Specific Antigen Sales by Type (2020-2025)
8.3 Middle East & Africa Prostate Specific Antigen Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Prostate Specific Antigen
10.3 Manufacturing Process Analysis of Prostate Specific Antigen
10.4 Industry Chain Structure of Prostate Specific Antigen
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Prostate Specific Antigen Distributors
11.3 Prostate Specific Antigen Customer
12 WORLD FORECAST REVIEW FOR PROSTATE SPECIFIC ANTIGEN BY GEOGRAPHIC REGION
12.1 Global Prostate Specific Antigen Market Size Forecast by Region
12.1.1 Global Prostate Specific Antigen Forecast by Region (2026-2031)
12.1.2 Global Prostate Specific Antigen Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Prostate Specific Antigen Forecast by Type (2026-2031)
12.7 Global Prostate Specific Antigen Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Advaxis, Inc.
13.1.1 Advaxis, Inc. Company Information
13.1.2 Advaxis, Inc. Prostate Specific Antigen Product Portfolios and Specifications
13.1.3 Advaxis, Inc. Prostate Specific Antigen Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Advaxis, Inc. Main Business Overview
13.1.5 Advaxis, Inc. Latest Developments
13.2 Aeterna Zentaris Inc.
13.2.1 Aeterna Zentaris Inc. Company Information
13.2.2 Aeterna Zentaris Inc. Prostate Specific Antigen Product Portfolios and Specifications
13.2.3 Aeterna Zentaris Inc. Prostate Specific Antigen Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Aeterna Zentaris Inc. Main Business Overview
13.2.5 Aeterna Zentaris Inc. Latest Developments
13.3 Bavarian Nordic A/S
13.3.1 Bavarian Nordic A/S Company Information
13.3.2 Bavarian Nordic A/S Prostate Specific Antigen Product Portfolios and Specifications
13.3.3 Bavarian Nordic A/S Prostate Specific Antigen Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bavarian Nordic A/S Main Business Overview
13.3.5 Bavarian Nordic A/S Latest Developments
13.4 Curevac AG
13.4.1 Curevac AG Company Information
13.4.2 Curevac AG Prostate Specific Antigen Product Portfolios and Specifications
13.4.3 Curevac AG Prostate Specific Antigen Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Curevac AG Main Business Overview
13.4.5 Curevac AG Latest Developments
13.5 GenSpera, Inc.
13.5.1 GenSpera, Inc. Company Information
13.5.2 GenSpera, Inc. Prostate Specific Antigen Product Portfolios and Specifications
13.5.3 GenSpera, Inc. Prostate Specific Antigen Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 GenSpera, Inc. Main Business Overview
13.5.5 GenSpera, Inc. Latest Developments
13.6 Inovio Pharmaceuticals, Inc.
13.6.1 Inovio Pharmaceuticals, Inc. Company Information
13.6.2 Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Product Portfolios and Specifications
13.6.3 Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Inovio Pharmaceuticals, Inc. Main Business Overview
13.6.5 Inovio Pharmaceuticals, Inc. Latest Developments
13.7 OncBioMune Pharmaceuticals Inc.
13.7.1 OncBioMune Pharmaceuticals Inc. Company Information
13.7.2 OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Product Portfolios and Specifications
13.7.3 OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 OncBioMune Pharmaceuticals Inc. Main Business Overview
13.7.5 OncBioMune Pharmaceuticals Inc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Prostate Specific Antigen Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Prostate Specific Antigen Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of G-115
Table 4. Major Players of INO-5150
Table 5. Major Players of ADXS-PSA
Table 6. Major Players of AEZS-120
Table 7. Major Players of Others
Table 8. Global Prostate Specific Antigen Sales by Type (2020-2025) & (K Pcs)
Table 9. Global Prostate Specific Antigen Sales Market Share by Type (2020-2025)
Table 10. Global Prostate Specific Antigen Revenue by Type (2020-2025) & ($ million)
Table 11. Global Prostate Specific Antigen Revenue Market Share by Type (2020-2025)
Table 12. Global Prostate Specific Antigen Sale Price by Type (2020-2025) & (USD/Pcs)
Table 13. Global Prostate Specific Antigen Sale by Application (2020-2025) & (K Pcs)
Table 14. Global Prostate Specific Antigen Sale Market Share by Application (2020-2025)
Table 15. Global Prostate Specific Antigen Revenue by Application (2020-2025) & ($ million)
Table 16. Global Prostate Specific Antigen Revenue Market Share by Application (2020-2025)
Table 17. Global Prostate Specific Antigen Sale Price by Application (2020-2025) & (USD/Pcs)
Table 18. Global Prostate Specific Antigen Sales by Company (2020-2025) & (K Pcs)
Table 19. Global Prostate Specific Antigen Sales Market Share by Company (2020-2025)
Table 20. Global Prostate Specific Antigen Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Prostate Specific Antigen Revenue Market Share by Company (2020-2025)
Table 22. Global Prostate Specific Antigen Sale Price by Company (2020-2025) & (USD/Pcs)
Table 23. Key Manufacturers Prostate Specific Antigen Producing Area Distribution and Sales Area
Table 24. Players Prostate Specific Antigen Products Offered
Table 25. Prostate Specific Antigen Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Prostate Specific Antigen Sales by Geographic Region (2020-2025) & (K Pcs)
Table 29. Global Prostate Specific Antigen Sales Market Share Geographic Region (2020-2025)
Table 30. Global Prostate Specific Antigen Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Prostate Specific Antigen Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Prostate Specific Antigen Sales by Country/Region (2020-2025) & (K Pcs)
Table 33. Global Prostate Specific Antigen Sales Market Share by Country/Region (2020-2025)
Table 34. Global Prostate Specific Antigen Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Prostate Specific Antigen Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Prostate Specific Antigen Sales by Country (2020-2025) & (K Pcs)
Table 37. Americas Prostate Specific Antigen Sales Market Share by Country (2020-2025)
Table 38. Americas Prostate Specific Antigen Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Prostate Specific Antigen Sales by Type (2020-2025) & (K Pcs)
Table 40. Americas Prostate Specific Antigen Sales by Application (2020-2025) & (K Pcs)
Table 41. APAC Prostate Specific Antigen Sales by Region (2020-2025) & (K Pcs)
Table 42. APAC Prostate Specific Antigen Sales Market Share by Region (2020-2025)
Table 43. APAC Prostate Specific Antigen Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Prostate Specific Antigen Sales by Type (2020-2025) & (K Pcs)
Table 45. APAC Prostate Specific Antigen Sales by Application (2020-2025) & (K Pcs)
Table 46. Europe Prostate Specific Antigen Sales by Country (2020-2025) & (K Pcs)
Table 47. Europe Prostate Specific Antigen Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Prostate Specific Antigen Sales by Type (2020-2025) & (K Pcs)
Table 49. Europe Prostate Specific Antigen Sales by Application (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Prostate Specific Antigen Sales by Country (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Prostate Specific Antigen Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Prostate Specific Antigen Sales by Type (2020-2025) & (K Pcs)
Table 53. Middle East & Africa Prostate Specific Antigen Sales by Application (2020-2025) & (K Pcs)
Table 54. Key Market Drivers & Growth Opportunities of Prostate Specific Antigen
Table 55. Key Market Challenges & Risks of Prostate Specific Antigen
Table 56. Key Industry Trends of Prostate Specific Antigen
Table 57. Prostate Specific Antigen Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Prostate Specific Antigen Distributors List
Table 60. Prostate Specific Antigen Customer List
Table 61. Global Prostate Specific Antigen Sales Forecast by Region (2026-2031) & (K Pcs)
Table 62. Global Prostate Specific Antigen Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Prostate Specific Antigen Sales Forecast by Country (2026-2031) & (K Pcs)
Table 64. Americas Prostate Specific Antigen Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Prostate Specific Antigen Sales Forecast by Region (2026-2031) & (K Pcs)
Table 66. APAC Prostate Specific Antigen Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Prostate Specific Antigen Sales Forecast by Country (2026-2031) & (K Pcs)
Table 68. Europe Prostate Specific Antigen Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Prostate Specific Antigen Sales Forecast by Country (2026-2031) & (K Pcs)
Table 70. Middle East & Africa Prostate Specific Antigen Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Prostate Specific Antigen Sales Forecast by Type (2026-2031) & (K Pcs)
Table 72. Global Prostate Specific Antigen Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Prostate Specific Antigen Sales Forecast by Application (2026-2031) & (K Pcs)
Table 74. Global Prostate Specific Antigen Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. Advaxis, Inc. Basic Information, Prostate Specific Antigen Manufacturing Base, Sales Area and Its Competitors
Table 76. Advaxis, Inc. Prostate Specific Antigen Product Portfolios and Specifications
Table 77. Advaxis, Inc. Prostate Specific Antigen Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Advaxis, Inc. Main Business
Table 79. Advaxis, Inc. Latest Developments
Table 80. Aeterna Zentaris Inc. Basic Information, Prostate Specific Antigen Manufacturing Base, Sales Area and Its Competitors
Table 81. Aeterna Zentaris Inc. Prostate Specific Antigen Product Portfolios and Specifications
Table 82. Aeterna Zentaris Inc. Prostate Specific Antigen Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Aeterna Zentaris Inc. Main Business
Table 84. Aeterna Zentaris Inc. Latest Developments
Table 85. Bavarian Nordic A/S Basic Information, Prostate Specific Antigen Manufacturing Base, Sales Area and Its Competitors
Table 86. Bavarian Nordic A/S Prostate Specific Antigen Product Portfolios and Specifications
Table 87. Bavarian Nordic A/S Prostate Specific Antigen Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Bavarian Nordic A/S Main Business
Table 89. Bavarian Nordic A/S Latest Developments
Table 90. Curevac AG Basic Information, Prostate Specific Antigen Manufacturing Base, Sales Area and Its Competitors
Table 91. Curevac AG Prostate Specific Antigen Product Portfolios and Specifications
Table 92. Curevac AG Prostate Specific Antigen Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Curevac AG Main Business
Table 94. Curevac AG Latest Developments
Table 95. GenSpera, Inc. Basic Information, Prostate Specific Antigen Manufacturing Base, Sales Area and Its Competitors
Table 96. GenSpera, Inc. Prostate Specific Antigen Product Portfolios and Specifications
Table 97. GenSpera, Inc. Prostate Specific Antigen Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. GenSpera, Inc. Main Business
Table 99. GenSpera, Inc. Latest Developments
Table 100. Inovio Pharmaceuticals, Inc. Basic Information, Prostate Specific Antigen Manufacturing Base, Sales Area and Its Competitors
Table 101. Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Product Portfolios and Specifications
Table 102. Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Inovio Pharmaceuticals, Inc. Main Business
Table 104. Inovio Pharmaceuticals, Inc. Latest Developments
Table 105. OncBioMune Pharmaceuticals Inc. Basic Information, Prostate Specific Antigen Manufacturing Base, Sales Area and Its Competitors
Table 106. OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Product Portfolios and Specifications
Table 107. OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. OncBioMune Pharmaceuticals Inc. Main Business
Table 109. OncBioMune Pharmaceuticals Inc. Latest Developments
Table 1. Prostate Specific Antigen Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Prostate Specific Antigen Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of G-115
Table 4. Major Players of INO-5150
Table 5. Major Players of ADXS-PSA
Table 6. Major Players of AEZS-120
Table 7. Major Players of Others
Table 8. Global Prostate Specific Antigen Sales by Type (2020-2025) & (K Pcs)
Table 9. Global Prostate Specific Antigen Sales Market Share by Type (2020-2025)
Table 10. Global Prostate Specific Antigen Revenue by Type (2020-2025) & ($ million)
Table 11. Global Prostate Specific Antigen Revenue Market Share by Type (2020-2025)
Table 12. Global Prostate Specific Antigen Sale Price by Type (2020-2025) & (USD/Pcs)
Table 13. Global Prostate Specific Antigen Sale by Application (2020-2025) & (K Pcs)
Table 14. Global Prostate Specific Antigen Sale Market Share by Application (2020-2025)
Table 15. Global Prostate Specific Antigen Revenue by Application (2020-2025) & ($ million)
Table 16. Global Prostate Specific Antigen Revenue Market Share by Application (2020-2025)
Table 17. Global Prostate Specific Antigen Sale Price by Application (2020-2025) & (USD/Pcs)
Table 18. Global Prostate Specific Antigen Sales by Company (2020-2025) & (K Pcs)
Table 19. Global Prostate Specific Antigen Sales Market Share by Company (2020-2025)
Table 20. Global Prostate Specific Antigen Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Prostate Specific Antigen Revenue Market Share by Company (2020-2025)
Table 22. Global Prostate Specific Antigen Sale Price by Company (2020-2025) & (USD/Pcs)
Table 23. Key Manufacturers Prostate Specific Antigen Producing Area Distribution and Sales Area
Table 24. Players Prostate Specific Antigen Products Offered
Table 25. Prostate Specific Antigen Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Prostate Specific Antigen Sales by Geographic Region (2020-2025) & (K Pcs)
Table 29. Global Prostate Specific Antigen Sales Market Share Geographic Region (2020-2025)
Table 30. Global Prostate Specific Antigen Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Prostate Specific Antigen Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Prostate Specific Antigen Sales by Country/Region (2020-2025) & (K Pcs)
Table 33. Global Prostate Specific Antigen Sales Market Share by Country/Region (2020-2025)
Table 34. Global Prostate Specific Antigen Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Prostate Specific Antigen Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Prostate Specific Antigen Sales by Country (2020-2025) & (K Pcs)
Table 37. Americas Prostate Specific Antigen Sales Market Share by Country (2020-2025)
Table 38. Americas Prostate Specific Antigen Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Prostate Specific Antigen Sales by Type (2020-2025) & (K Pcs)
Table 40. Americas Prostate Specific Antigen Sales by Application (2020-2025) & (K Pcs)
Table 41. APAC Prostate Specific Antigen Sales by Region (2020-2025) & (K Pcs)
Table 42. APAC Prostate Specific Antigen Sales Market Share by Region (2020-2025)
Table 43. APAC Prostate Specific Antigen Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Prostate Specific Antigen Sales by Type (2020-2025) & (K Pcs)
Table 45. APAC Prostate Specific Antigen Sales by Application (2020-2025) & (K Pcs)
Table 46. Europe Prostate Specific Antigen Sales by Country (2020-2025) & (K Pcs)
Table 47. Europe Prostate Specific Antigen Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Prostate Specific Antigen Sales by Type (2020-2025) & (K Pcs)
Table 49. Europe Prostate Specific Antigen Sales by Application (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Prostate Specific Antigen Sales by Country (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Prostate Specific Antigen Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Prostate Specific Antigen Sales by Type (2020-2025) & (K Pcs)
Table 53. Middle East & Africa Prostate Specific Antigen Sales by Application (2020-2025) & (K Pcs)
Table 54. Key Market Drivers & Growth Opportunities of Prostate Specific Antigen
Table 55. Key Market Challenges & Risks of Prostate Specific Antigen
Table 56. Key Industry Trends of Prostate Specific Antigen
Table 57. Prostate Specific Antigen Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Prostate Specific Antigen Distributors List
Table 60. Prostate Specific Antigen Customer List
Table 61. Global Prostate Specific Antigen Sales Forecast by Region (2026-2031) & (K Pcs)
Table 62. Global Prostate Specific Antigen Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Prostate Specific Antigen Sales Forecast by Country (2026-2031) & (K Pcs)
Table 64. Americas Prostate Specific Antigen Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Prostate Specific Antigen Sales Forecast by Region (2026-2031) & (K Pcs)
Table 66. APAC Prostate Specific Antigen Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Prostate Specific Antigen Sales Forecast by Country (2026-2031) & (K Pcs)
Table 68. Europe Prostate Specific Antigen Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Prostate Specific Antigen Sales Forecast by Country (2026-2031) & (K Pcs)
Table 70. Middle East & Africa Prostate Specific Antigen Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Prostate Specific Antigen Sales Forecast by Type (2026-2031) & (K Pcs)
Table 72. Global Prostate Specific Antigen Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Prostate Specific Antigen Sales Forecast by Application (2026-2031) & (K Pcs)
Table 74. Global Prostate Specific Antigen Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. Advaxis, Inc. Basic Information, Prostate Specific Antigen Manufacturing Base, Sales Area and Its Competitors
Table 76. Advaxis, Inc. Prostate Specific Antigen Product Portfolios and Specifications
Table 77. Advaxis, Inc. Prostate Specific Antigen Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Advaxis, Inc. Main Business
Table 79. Advaxis, Inc. Latest Developments
Table 80. Aeterna Zentaris Inc. Basic Information, Prostate Specific Antigen Manufacturing Base, Sales Area and Its Competitors
Table 81. Aeterna Zentaris Inc. Prostate Specific Antigen Product Portfolios and Specifications
Table 82. Aeterna Zentaris Inc. Prostate Specific Antigen Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Aeterna Zentaris Inc. Main Business
Table 84. Aeterna Zentaris Inc. Latest Developments
Table 85. Bavarian Nordic A/S Basic Information, Prostate Specific Antigen Manufacturing Base, Sales Area and Its Competitors
Table 86. Bavarian Nordic A/S Prostate Specific Antigen Product Portfolios and Specifications
Table 87. Bavarian Nordic A/S Prostate Specific Antigen Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Bavarian Nordic A/S Main Business
Table 89. Bavarian Nordic A/S Latest Developments
Table 90. Curevac AG Basic Information, Prostate Specific Antigen Manufacturing Base, Sales Area and Its Competitors
Table 91. Curevac AG Prostate Specific Antigen Product Portfolios and Specifications
Table 92. Curevac AG Prostate Specific Antigen Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Curevac AG Main Business
Table 94. Curevac AG Latest Developments
Table 95. GenSpera, Inc. Basic Information, Prostate Specific Antigen Manufacturing Base, Sales Area and Its Competitors
Table 96. GenSpera, Inc. Prostate Specific Antigen Product Portfolios and Specifications
Table 97. GenSpera, Inc. Prostate Specific Antigen Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. GenSpera, Inc. Main Business
Table 99. GenSpera, Inc. Latest Developments
Table 100. Inovio Pharmaceuticals, Inc. Basic Information, Prostate Specific Antigen Manufacturing Base, Sales Area and Its Competitors
Table 101. Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Product Portfolios and Specifications
Table 102. Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Inovio Pharmaceuticals, Inc. Main Business
Table 104. Inovio Pharmaceuticals, Inc. Latest Developments
Table 105. OncBioMune Pharmaceuticals Inc. Basic Information, Prostate Specific Antigen Manufacturing Base, Sales Area and Its Competitors
Table 106. OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Product Portfolios and Specifications
Table 107. OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. OncBioMune Pharmaceuticals Inc. Main Business
Table 109. OncBioMune Pharmaceuticals Inc. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Prostate Specific Antigen
Figure 2. Prostate Specific Antigen Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Prostate Specific Antigen Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Prostate Specific Antigen Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Prostate Specific Antigen Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Prostate Specific Antigen Sales Market Share by Country/Region (2024)
Figure 10. Prostate Specific Antigen Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of G-115
Figure 12. Product Picture of INO-5150
Figure 13. Product Picture of ADXS-PSA
Figure 14. Product Picture of AEZS-120
Figure 15. Product Picture of Others
Figure 16. Global Prostate Specific Antigen Sales Market Share by Type in 2025
Figure 17. Global Prostate Specific Antigen Revenue Market Share by Type (2020-2025)
Figure 18. Prostate Specific Antigen Consumed in Prostate Cancer
Figure 19. Global Prostate Specific Antigen Market: Prostate Cancer (2020-2025) & (K Pcs)
Figure 20. Prostate Specific Antigen Consumed in Metastatic Hormone Refractory Prostate Cancer
Figure 21. Global Prostate Specific Antigen Market: Metastatic Hormone Refractory Prostate Cancer (2020-2025) & (K Pcs)
Figure 22. Prostate Specific Antigen Consumed in Others
Figure 23. Global Prostate Specific Antigen Market: Others (2020-2025) & (K Pcs)
Figure 24. Global Prostate Specific Antigen Sale Market Share by Application (2024)
Figure 25. Global Prostate Specific Antigen Revenue Market Share by Application in 2025
Figure 26. Prostate Specific Antigen Sales by Company in 2025 (K Pcs)
Figure 27. Global Prostate Specific Antigen Sales Market Share by Company in 2025
Figure 28. Prostate Specific Antigen Revenue by Company in 2025 ($ millions)
Figure 29. Global Prostate Specific Antigen Revenue Market Share by Company in 2025
Figure 30. Global Prostate Specific Antigen Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Prostate Specific Antigen Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Prostate Specific Antigen Sales 2020-2025 (K Pcs)
Figure 33. Americas Prostate Specific Antigen Revenue 2020-2025 ($ millions)
Figure 34. APAC Prostate Specific Antigen Sales 2020-2025 (K Pcs)
Figure 35. APAC Prostate Specific Antigen Revenue 2020-2025 ($ millions)
Figure 36. Europe Prostate Specific Antigen Sales 2020-2025 (K Pcs)
Figure 37. Europe Prostate Specific Antigen Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Prostate Specific Antigen Sales 2020-2025 (K Pcs)
Figure 39. Middle East & Africa Prostate Specific Antigen Revenue 2020-2025 ($ millions)
Figure 40. Americas Prostate Specific Antigen Sales Market Share by Country in 2025
Figure 41. Americas Prostate Specific Antigen Revenue Market Share by Country (2020-2025)
Figure 42. Americas Prostate Specific Antigen Sales Market Share by Type (2020-2025)
Figure 43. Americas Prostate Specific Antigen Sales Market Share by Application (2020-2025)
Figure 44. United States Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Prostate Specific Antigen Sales Market Share by Region in 2025
Figure 49. APAC Prostate Specific Antigen Revenue Market Share by Region (2020-2025)
Figure 50. APAC Prostate Specific Antigen Sales Market Share by Type (2020-2025)
Figure 51. APAC Prostate Specific Antigen Sales Market Share by Application (2020-2025)
Figure 52. China Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 56. India Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Prostate Specific Antigen Sales Market Share by Country in 2025
Figure 60. Europe Prostate Specific Antigen Revenue Market Share by Country (2020-2025)
Figure 61. Europe Prostate Specific Antigen Sales Market Share by Type (2020-2025)
Figure 62. Europe Prostate Specific Antigen Sales Market Share by Application (2020-2025)
Figure 63. Germany Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 64. France Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Prostate Specific Antigen Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Prostate Specific Antigen Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa Prostate Specific Antigen Sales Market Share by Application (2020-2025)
Figure 71. Egypt Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Prostate Specific Antigen in 2025
Figure 77. Manufacturing Process Analysis of Prostate Specific Antigen
Figure 78. Industry Chain Structure of Prostate Specific Antigen
Figure 79. Channels of Distribution
Figure 80. Global Prostate Specific Antigen Sales Market Forecast by Region (2026-2031)
Figure 81. Global Prostate Specific Antigen Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global Prostate Specific Antigen Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global Prostate Specific Antigen Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global Prostate Specific Antigen Sales Market Share Forecast by Application (2026-2031)
Figure 85. Global Prostate Specific Antigen Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Prostate Specific Antigen
Figure 2. Prostate Specific Antigen Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Prostate Specific Antigen Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Prostate Specific Antigen Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Prostate Specific Antigen Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Prostate Specific Antigen Sales Market Share by Country/Region (2024)
Figure 10. Prostate Specific Antigen Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of G-115
Figure 12. Product Picture of INO-5150
Figure 13. Product Picture of ADXS-PSA
Figure 14. Product Picture of AEZS-120
Figure 15. Product Picture of Others
Figure 16. Global Prostate Specific Antigen Sales Market Share by Type in 2025
Figure 17. Global Prostate Specific Antigen Revenue Market Share by Type (2020-2025)
Figure 18. Prostate Specific Antigen Consumed in Prostate Cancer
Figure 19. Global Prostate Specific Antigen Market: Prostate Cancer (2020-2025) & (K Pcs)
Figure 20. Prostate Specific Antigen Consumed in Metastatic Hormone Refractory Prostate Cancer
Figure 21. Global Prostate Specific Antigen Market: Metastatic Hormone Refractory Prostate Cancer (2020-2025) & (K Pcs)
Figure 22. Prostate Specific Antigen Consumed in Others
Figure 23. Global Prostate Specific Antigen Market: Others (2020-2025) & (K Pcs)
Figure 24. Global Prostate Specific Antigen Sale Market Share by Application (2024)
Figure 25. Global Prostate Specific Antigen Revenue Market Share by Application in 2025
Figure 26. Prostate Specific Antigen Sales by Company in 2025 (K Pcs)
Figure 27. Global Prostate Specific Antigen Sales Market Share by Company in 2025
Figure 28. Prostate Specific Antigen Revenue by Company in 2025 ($ millions)
Figure 29. Global Prostate Specific Antigen Revenue Market Share by Company in 2025
Figure 30. Global Prostate Specific Antigen Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Prostate Specific Antigen Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Prostate Specific Antigen Sales 2020-2025 (K Pcs)
Figure 33. Americas Prostate Specific Antigen Revenue 2020-2025 ($ millions)
Figure 34. APAC Prostate Specific Antigen Sales 2020-2025 (K Pcs)
Figure 35. APAC Prostate Specific Antigen Revenue 2020-2025 ($ millions)
Figure 36. Europe Prostate Specific Antigen Sales 2020-2025 (K Pcs)
Figure 37. Europe Prostate Specific Antigen Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Prostate Specific Antigen Sales 2020-2025 (K Pcs)
Figure 39. Middle East & Africa Prostate Specific Antigen Revenue 2020-2025 ($ millions)
Figure 40. Americas Prostate Specific Antigen Sales Market Share by Country in 2025
Figure 41. Americas Prostate Specific Antigen Revenue Market Share by Country (2020-2025)
Figure 42. Americas Prostate Specific Antigen Sales Market Share by Type (2020-2025)
Figure 43. Americas Prostate Specific Antigen Sales Market Share by Application (2020-2025)
Figure 44. United States Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Prostate Specific Antigen Sales Market Share by Region in 2025
Figure 49. APAC Prostate Specific Antigen Revenue Market Share by Region (2020-2025)
Figure 50. APAC Prostate Specific Antigen Sales Market Share by Type (2020-2025)
Figure 51. APAC Prostate Specific Antigen Sales Market Share by Application (2020-2025)
Figure 52. China Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 56. India Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Prostate Specific Antigen Sales Market Share by Country in 2025
Figure 60. Europe Prostate Specific Antigen Revenue Market Share by Country (2020-2025)
Figure 61. Europe Prostate Specific Antigen Sales Market Share by Type (2020-2025)
Figure 62. Europe Prostate Specific Antigen Sales Market Share by Application (2020-2025)
Figure 63. Germany Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 64. France Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Prostate Specific Antigen Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Prostate Specific Antigen Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa Prostate Specific Antigen Sales Market Share by Application (2020-2025)
Figure 71. Egypt Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Prostate Specific Antigen Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Prostate Specific Antigen in 2025
Figure 77. Manufacturing Process Analysis of Prostate Specific Antigen
Figure 78. Industry Chain Structure of Prostate Specific Antigen
Figure 79. Channels of Distribution
Figure 80. Global Prostate Specific Antigen Sales Market Forecast by Region (2026-2031)
Figure 81. Global Prostate Specific Antigen Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global Prostate Specific Antigen Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global Prostate Specific Antigen Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global Prostate Specific Antigen Sales Market Share Forecast by Application (2026-2031)
Figure 85. Global Prostate Specific Antigen Revenue Market Share Forecast by Application (2026-2031)